Provided by Tiger Fintech (Singapore) Pte. Ltd.

TriSalus Life Sciences Inc.

5.64
-0.0100-0.18%
Volume:6.84K
Turnover:38.64K
Market Cap:182.02M
PE:-4.30
High:5.70
Open:5.66
Low:5.53
Close:5.65
Loading ...

Company Profile

Company Name:
TriSalus Life Sciences Inc.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
110
Office Location:
6272 West 91st Avenue,Westminster,Colorado,United States
Zip Code:
80031
Fax:
- -
Introduction:
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.

Directors

Name
Position
Christopher C. Dewey
Chief Executive Officer and Director
Karim Karti
Chairman
David J. Matlin
Chief Financial Officer and Director
David L. Treadwell
Director
Manuel Aguero
Director
Martin Roche
Director
Thierry Thaure
Director

Shareholders

Name
Position
Christopher C. Dewey
Chief Executive Officer and Director
David J. Matlin
Chief Financial Officer and Director
Robert H. Weiss
Chief Administrative Officer and Secretary